Psychedelic trips could soon be part of therapy — here’s what those sessions will look like


Nature's Lab Gold Probiotics

Medicinal uses for psilocybin include depression, PTSD and other mental disorders, and as more clinical data comes in, a recent spate of public offering has raised billions of dollars for the emerging mental health field.
Medicinal uses for psilocybin include depression, PTSD and other mental disorders, and as more clinical data comes in, a recent spate of public offering has raised billions of dollars for the emerging mental health field.The Washington Post | The Washington Post | Getty Images

Investors are opening their minds and wallets to the possibilities of psychedelic-assisted therapies.

Three biopharmaceutical companies aiming to make psychedelic drugs to treat mental health disorders have gone public in recent months: Peter Thiel-backed Atai Life Sciences IPO’d in June and now has a market cap of $2.6 billion; MindMed went public in April and now has a market cap of more than $1 billion; and Compass Pathways IPO’d in November, with a current market cap of nearly $1.5 billion.  Keep Reading


Researchers provide therapeutic support in the treatment room at one of the study sites for MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD.
Researchers provide therapeutic support in the treatment room at one of the study sites for MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD.Courtesy of MAPS.

Oxygen Plus


Research-grade capsules for use in MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD.
Research-grade capsules for use in MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD.Courtesy of MAPS.


Enjoy a Relaxing Cup of Coffee from CBD Resellers Today!


steves-goods-cbd-cbg-hemp-blueberry-watermelon-oil-tincture

Woman who leapt to her death from NYC high-rise with her dog ID’d

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *